Genetic CCR2 deficiency consistently reduced infarct size and macrophage accumulation in the acute phase of cerebral ischemia, while the transgenic mice overexpressing CCL2 aggravated cerebral infarction and immune cell accumulation [55]. The gene discussed is CCR2; the disease is brain infarction.